Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 5th November 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EVAC webinar 2020 now available to view online
Colistin is a Gram-negative antibiotic widely used in pig and poultry medicine.

Speakers discuss colistin use and the impact of a potential ban

Recordings from the European Veterinary Antibiotics Conference (EVAC) 2020 are now available to view online.

This year's conference focused on the use of colistin and featured presentations from pharmacological, clinical and epidemiological specialists on the topic.

Speakers at EVAC 2020 discussed the use of colistin and the rising fears from veterinary professionals over a potential ban on the antibiotic. This ban could, according to the speakers, have a major negative impact on animal health and welfare – as well as public health.

Xavier Chatenet, a veterinary surgeon specialising in poultry health, spoke about the lack of alternatives to colistin for the group treatment of poultry. He argued that colistin is an essential veterinary product which, if banned, could lead to greater resistance problems with the alternatives.

Dr Pascal Richez, European specialist in veterinary pharmacology and toxicology, was next to speak. Focusing on misconceptions surrounding antibiotic resistance and the importance of clinical breakpoints to help clinicians determine if a pathogen is likely to respond to treatment.

The webinar concluded with a discussion of the use of colistin in human health care, led by Dr Boudewijn Catry, epidemiologist and head of the Belgian service for healthcare-associated infections & antimicrobial resistance. He confirmed that 'the need to be concerned for colistin resistance in public health care is very low’ adding that, in human medicine, many alternatives are coming on the market.

Highlights of the EVAC webinar can be viewed here.

Become a member or log in to add this story to your CPD history

FIVP announces third series of Practice Matters

News Story 1
 The Federation of Independent Veterinary Practices (FIVP) has announced a third season of its podcast, Practice Matters.

Hosted by Ian Wolstenholme, series three will focus on the Competition and Markets Authority (CMA) investigation, including a discussion about some of the expected impacts on independent veterinary colleagues.

Episode one launches on 13th January with guests Drs David Reader and Scott Summers, who will draw on their research into the CMA investigation and provide insights into themes such as transparency, pricing and consumer trust.

Ian Wolstenholme said: "In its third series, we will try and hone in on what the changes will mean in reality for independent practices with advice and guidance on implementation and delivery, drawing on the experience of our own team and other experts in the profession. Hope you can join us soon!" 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk